VIVITONIN 50 TABLETS FOR AGED DOGS

Страна: Австралія

мова: англійська

Джерело: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Активний інгредієнт:

PROPENTOFYLLINE

Доступна з:

INTERVET AUSTRALIA PTY LIMITED

ІПН (Міжнародна Ім'я):

propentofylline(50mg/Tb)

Фармацевтична форма:

ORAL TABLET

Склад:

PROPENTOFYLLINE ALKALOID Active 50.0 mg/Tb

Одиниць в упаковці:

#50 Tabs; #Bottle; 60 Tablets; Foil strip

Клас:

VM - Veterinary Medicine

Виробник:

INTERVET AUSTRALIA

Терапевтична група:

DOG - OLDER

Терапевтична области:

CARDIOVASCULAR SYSTEM

Терапевтичні свідчення:

ALLEVIATION OF DULLNESS, LETHARGY | LONGEVITY | FOR OLDER DOGS | OLD AGE | PROLONG LIFE

Огляд продуктів:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG - OLDER: [ALLEVIATION OF DULLNESS, LETHARGY, LONGEVITY]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG - OLDER: [ALLEVIATION OF DULLNESS, LETHARGY, LONGEVITY]; For the alleviation of dullness, lethargy and improvement in overall demeanour in older dogs. May help in slowing development of hearing/sight defects associated with ageing and also slow the development of cataracts in aged animals.Contraindicated in pregnant or lactating bitches. Allergic skin reactions (e.g. urticaria) may occur rarely after administration.

Статус Авторизація:

Registered

Дата Авторизація:

2023-07-01

інформаційний буклет

Registered
Product
Name;
Pagelo
f4
I
Viv
ilon
i
~50
Pack Sizes ; 60 tablets
Oate (Vers ion Control): ORAFT NZ Opt1on 1
111
1212009
AU reviewed 16112109
ACVM approved 01
April
2010 Warn ings
removed 27 Ma
10
OeS~~i~tlOn;
Carto n
&
Insert
TeX T
{
ne
~
;
incorpo rati ng dose
APVMA:
Pend ing
chan
e and new ACVM Jabel sta lements
Panel
labels
te xt
above the header and below the fo ot er
are
not
included In this labe l
text.
[INSERT]
PRESCRIPTION ANIMAL REMEOY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
VIVITONIN@50
TABLETS FOR AGED DOGS
Eac h film-coated tab let
contains 50mg propentofy
JJine.
MODE
OF
ACT
ION
V ivito nin acts primarily by producing a m arked improvement
in
the
m icro-ci rcu lat ion
a nd the refore by increasing the oxygen supp ly in the per iphera l
and cerebral
ar
eas
.
It
may start
to take effect
afte r only a few days , de pend ing on
the
cl inica l
sig ns .
The
clinical
signs can be expected to retu rn once treatment has been dis
continued.
INDICAT
IONS
C ond it ions
ass
ociate d w ith the ageing process in dogs,
such as let hargy, tiredness ,
. apathy , stiff ga it, difficu lty in stan di ng up and walking ,
lack
of
appetite ,
was
ting ,
alopecia, d ull
coat,
when no specific ca use of th
ese
conditions can be fou nd,
V ivito nin
may
hel p in slow ing the development
of
hearing and sight de fects
assoc
iated with agei ng and also slow the develop me nt
of
cataracts in aged anima ls.
CONTRA
INDICAT
IONS
Co ntraind icated in pregna nt
or lactating bitches, as
the
compo
und has
not
yet
been
eva luated for these anima ls .
DOSAGE
AND
ADM
INISTRATION
6
- 10
mg propentofylline/kg bodyweight dai ly divi
ded
into two doses give n am & pm
as fo llows:
Bodywei nht
Tabl ets
I
Dailv Tota l
~
Da ily total
Ka
a.m
D.
m
Ta ble ts (SOma l
Dos e (mg/kal
<5
kg
Y.
Y.
II,
6.3 -
10.0
5
-8
kg
II,
II,
1
6.3 -
10.0
9-
15 kg
1
1
2
6.7 -
11.1
1
6-
25 kg
1
~
1
%
3
6.0
-
g.4
26
-33k
g
2
2
4
6.1
-7.7
34
-50
kg
3
3
6
6.0
-
8.8
The tab let can be adm inis
ter
ed directly onto the back of the tongue or can be mixed

Характеристики продукта

PRODUCT NAME: VIVITONIN® 50 & 100 TABLETS FOR AGED DOGS
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JULY, 2009
PAGE: 1 OF 5
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: [phone]
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
Propentofylline is a xanthine derivative.
TRADE NAME:
VIVITONIN
® 50 & 100 TABLETS FOR AGED DOGS
PRODUCT CODE:
176445, 176560
RECOMMENDED USE:
For the alleviation of dullness, lethargy and improvement in overall
demeanor in older
dogs. Vivitonin widens blood vessels and makes blood less sticky,
improving circulation.
APVMA NO:
51394, 49892
CREATION DATE:
November, 2006
THIS VERSION ISSUED:
July, 2009
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
Not Hazardous - No criteria found.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
Ochre coloured tablets.
ODOUR:
No odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
INHALATION:
SHORT TERM EXPOSURE:
Long term inhalation of high amounts of any nuisance dust may overload
lung clearance
mechanism. Available data indicates that this product is not harmful.
However product may be mildly irritating, although
unlikely to cause anything more than mild transient discomfort.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. In addition product is unlikely to cause any discomfort in
normal use.
LONG TERM EXPOSURE:
No data for health effects associated with long term ski